Current Trends in Circulating Biomarkers for Melanoma Detection
Melanomas have increased in global incidence and are the leading cause of skin cancer deaths. Whilst the majority of early-stage, non-metastatic melanomas can be cured with surgical excision alone, ~5% of patients with early melanomas will experience recurrence following a variable disease-free inte...
Main Authors: | Nancy Huang, Katie J. Lee, Mitchell S. Stark |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.873728/full |
Similar Items
-
Endovascular image-guided sampling of tumor-draining veins provides an enriched source of oncological biomarkers
by: Anobel Tamrazi, et al.
Published: (2023-03-01) -
Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients
by: Svenja Schneegans, et al.
Published: (2020-05-01) -
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
by: Steven P. Rowe, et al.
Published: (2018-10-01) -
Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?
by: Benedetta Cena, et al.
Published: (2022-05-01) -
Liquid Biopsies in Lung Cancer
by: Marcel Kemper, et al.
Published: (2023-02-01)